In October 2026, the independent Fonagy review of mental health conditions, autism and ADHD called for tighter regulation and oversight of private providers as it has “strong concerns about consistency and quality” of the assessments carried out.
The review warned that there was no “consistent oversight, transparency or quality assurance” of services supplied by the private sector, and a lack of data meant that “commissioners often cannot see what they are paying for”.
The review was commissioned in December 2025 by the then health secretary, Wes Streeting due to concerns over the rise of people making sickness benefit claims due to mental health, autism and ADHD diagnoses.
Led by Prof Peter Fonagy, a clinical psychologist and psychoanalyst at University College London, the review considered all aspects of the sector, including the involvement of the private sector.
There have been concerns for some time over the involvement of private providers in this field. The lack of NHS staff and infrastructure for carrying out assessments for neurodevelopmental disorders (ADHD and autism) has led to long waiting times, in some cases of years. As a result, people have increasingly turned to private providers, either privately funded assessments or, more commonly, via the Right to Choose referral system. This latter system means that the NHS funds assessments by private providers.
This sector has provided rich pickings for private companies, including attracting private equity investment, which often indicates investors expect large returns in a short time. Companies have been set up around the country to provide assessment services fueled by the Right-to-Choose referral system. With approval to work by a single ICB, a company can conduct assessments anywhere in England, often using remote assessments.
Full article on The Lowdown, 12 November 2026